1. Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report. (1st August 2018) Authors: Podlipnik, S.; Guijarro, F.; Combalia, A.; To‐Figueras, J.; Badenas, C.; Costa, D.; Rozman, M.; Jorge, S.; Aguilera, P.; Gaya, A. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report. (2nd March 2018) Authors: Podlipnik, S.; Guijarro, F.; Combalia, A.; To‐Figueras, J.; Badenas, C.; Costa, D.; Rozman, M.; Jorge, S.; Aguilera, P.; Gaya, A. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Age as a prognostic factor in thick and ultrathick melanomas without lymph node metastasis. (22nd May 2020) Authors: Boada, A.; Tejera‐Vaquerizo, A.; Ribero, S.; Puig, S.; Moreno‐Ramírez, D.; Osella‐Abate, S.; Cassoni, P.; Malvehy, J.; Podlipnik, S.; Requena, C.; Manrique‐Silva, E.; Rios‐Martin, J.J.; Ferrándiz, C.; Nagore, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 9(2020) Page Start: e513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost‐effectiveness analysis of imaging strategy for an intensive follow‐up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma. (19th September 2018) Authors: Podlipnik, S.; Moreno‐Ramírez, D.; Carrera, C.; Barreiro, A.; Manubens, E.; Ferrandiz‐Pulido, L.; Sánchez, M.; Vidal‐Sicart, S.; Malvehy, J.; Puig, S. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost‐effectiveness analysis of imaging strategy for an intensive follow‐up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma. (1st May 2019) Authors: Podlipnik, S.; Moreno‐Ramírez, D.; Carrera, C.; Barreiro, A.; Manubens, E.; Ferrandiz‐Pulido, L.; Sánchez, M.; Vidal‐Sicart, S.; Malvehy, J.; Puig, S. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Detection of cell‐free circulating BRAFV600E by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance. (12th August 2019) Authors: Calbet‐Llopart, N.; Potrony, M.; Tell‐Martí, G.; Carrera, C.; Barreiro, A.; Aguilera, P.; Podlipnik, S.; Puig, S.; Malvehy, J.; Puig‐Butillé, J.A. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Detection of cell‐free circulating BRAFV600E by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance. (1st February 2020) Authors: Calbet‐Llopart, N.; Potrony, M.; Tell‐Martí, G.; Carrera, C.; Barreiro, A.; Aguilera, P.; Podlipnik, S.; Puig, S.; Malvehy, J.; Puig‐Butillé, J.A. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dynamics of plasma cytokines in a patient with deficiency of interleukin‐36 receptor antagonist successfully treated with anakinra. (1st April 2018) Authors: Podlipnik, S.; Morgado‐Carrasco, D.; Fustà‐Novell, X.; Mensa‐Vilaró, A.; Arostegui, J.I.; Alsina‐Gibert, M.; Mascaró Jr, J.M. Journal: British journal of dermatology Issue: Volume 178:Number 4(2018) Page Start: e258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dynamics of plasma cytokines in a patient with deficiency of interleukin‐36 receptor antagonist successfully treated with anakinra. (7th February 2018) Authors: Podlipnik, S.; Morgado‐Carrasco, D.; Fustà‐Novell, X.; Mensa‐Vilaró, A.; Arostegui, J.I.; Alsina‐Gibert, M.; Mascaró Jr, J.M. Journal: British journal of dermatology Issue: Volume 178:Number 4(2018) Page Start: e258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Early outcome of a 31‐gene expression profile test in 86 AJCC stage IB‐II melanoma patients. A prospective multicentre cohort study. (28th February 2019) Authors: Podlipnik, S.; Carrera, C.; Boada, A.; Richarz, N.A.; López‐Estebaranz, J.L.; Pinedo‐Moraleda, F.; Elosua‐González, M.; Martín‐González, M.M.; Carrillo‐Gijón, R.; Redondo, P.; Moreno, E.; Malvehy, J.; Puig, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 5(2019) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗